Rajesh Narasimamurthy

6PUBLICATIONS
18CO-AUTHORS
Causes and prevention of crimeCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPopulation trends and policies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 02, 2024
Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein kinase 1.

Rachel L Harold, Nikhil K Tulsian, Rajesh Narasimamurthy

|Apr 23, 2024
Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis.

Yu Wang, Rajesh Narasimamurthy, Meng Qu

|May 02, 2020
Mutation of a PER2 phosphodegron perturbs the circadian phosphoswitch.

Shusaku Masuda, Rajesh Narasimamurthy, Hikari Yoshitane

|Feb 12, 2020
Casein kinase 1 dynamics underlie substrate selectivity and the PER2 circadian phosphoswitch.

Jonathan M Philpott, Rajesh Narasimamurthy, Clarisse G Ricci

|Jan 30, 2016
Targeting NF-κB in glioblastoma: A therapeutic approach.

Dinorah Friedmann-Morvinski, Rajesh Narasimamurthy, Yifeng Xia

Pageof 1